Advertisement

Topics

#news #biotech Daiichi DMD trial misses primary efficacy endpoint

07:41 EDT 25 Apr 2018 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Daiichi DMD trial misses primary efficacy endpoint .An early-phase trial of Daiichi Sankyo’s Duchenne muscular dystrophy (DMD) drug has failed to show clear evidence of efficacy. But, buoyed … Continue reading

Cet article #news #biotech Daiichi DMD trial misses primary efficacy endpoint est apparu en premier sur Biotech 365.

Original Article: #news #biotech Daiichi DMD trial misses primary efficacy endpoint

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Daiichi DMD trial misses primary efficacy endpoint"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...